Archives

With conversations around gender equity in the workplace continuing across the country, Cardinal Health emphasized the company's ongoing commitment to promoting and supporting the advancement of...

In honor of Patient Safety Awareness Week, Cardinal Health and the Cardinal Health Foundation are reinforcing their ongoing commitment to improving patient safety across the continuum of care...

Cardinal Health, Inc. (NYSE: CAH) today announced that it has received notice of an unsolicited "mini-tender" offer by TRC Capital Corporation (TRC Capital) to purchase up to 2 million of Cardinal...

As a company who embraces the knowledge and diverse perspectives of all employees, Cardinal Health was again recognized among the nation's best workplaces for female advancement as a Top Company...

Cardinal Health (NYSE: CAH) today reported second-quarter fiscal year 2018 revenue of $35.2 billion, an increase of 6 percent. The company also reported a decline in GAAP operating earnings of 26...

Cardinal Health (NYSE: CAH) today announced that its board of directors has elected Akhil Johri, Executive Vice President and Chief Financial Officer of United Technologies, to the Cardinal Health...

Cardinal Health (NYSE:CAH) today announced that its board of directors approved a regular quarterly dividend of $0.4624 per share, payable April 15, 2018 to shareholders of record on April 2,...

Cardinal Health (NYSE: CAH) today announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharma"). The sale...

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2018 on February 8 prior to the opening of trading on the New York Stock Exchange. The company...

DUBLIN, Ohio, January 11, 2018 — Cordis, a Cardinal Health company, and Medinol today announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States...